These data demonstrated that VPS35 D620N mutation promotes accumulation and aggregation of α‐syn in vivo for the first time and thus support the notion that VPS35 mutation likely promotes the development of α‐syn pathology in PD. The gene discussed is VPS35; the disease is Parkinson disease.